The scientific approach and the relevance of the physiological markers recorded by the application have been validated by two studies, one by the Besançon CHU (university hospital), and the other by the Nice CHU. A scientific paper on of one of these studies was published in the journal Medicine and Rehabilitation.
Codesna has also incorporated its technology into a software programme, CODESNA_HRV, which analyses heart rate variability and enables researchers, scientists and doctors to quickly assess an individual’s overall physiological balance, and to monitor it over time.
The company plans to develop new versions of its solution, with a new sensor positioned on the finger, and cloud-based software integration, to enable more data to be processed and cross-referenced and to further boost the effectiveness of the system. It intends to raise capital early in 2019 to support this.
Codesna was a winner in the French IoT 2018 acceleration programme, and will be exhibiting with La Poste at the 2019 CES in Las Vegas.
More information is available on the Codesna website.